Adaptin Bio (APTN) Notes Payables (2022 - 2024)
Adaptin Bio (APTN) posted Notes Payables of $544957.0 for Q4 2024, up 295.57% sequentially from $137764.0 in Q3 2024, and up 570.97% YoY from $81219.0 in Q1 2024.
Adaptin Bio (APTN) Notes Payables (2022 - 2024) Analysis & Trends
Adaptin Bio has reported Notes Payables for 3 years, with the latest figure at $544957.0 in Q4 2024.
- Quarterly Notes Payables rose 570.97% year-over-year to $544957.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $544957.0 (up 570.97% YoY) and the FY2024 annual result came in at $544957.0, up 570.97% from the prior year.
- Notes Payables grew to $544957.0 in Q4 2024 per APTN's latest filing, from $137764.0 in the prior quarter.
- Over five years, Notes Payables peaked at $544957.0 in Q4 2024 and troughed at $304.0 in Q4 2022.
- A 3-year average of $140129.6 and a median of $81219.0 in 2023 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2023 and 2024: Notes Payables surged 26616.78% in 2023, then jumped 502.33% in 2024.
- Over 3 years, Notes Payables stood at $304.0 in 2022, then soared by 26616.78% to $81219.0 in 2023, then surged by 570.97% to $544957.0 in 2024.
- According to Business Quant data, Notes Payables over the past three periods registered $544957.0, $137764.0, and $112572.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 544,957.00 |
| Sep 30, 2024 | 137,764.00 |
| Jun 30, 2024 | 112,572.00 |
| Mar 31, 2024 | 81,219.00 |
| Dec 31, 2023 | 81,219.00 |
| Sep 30, 2023 | 22,872.00 |
| Dec 31, 2022 | 304.00 |